Genetically Modified Pest-Protected Plants: Science and Regulation

Committee on Genetically Modified Pest-Protected Plants
Board on Agriculture and Natural Resources
National Research Council
National Academy Press
Washington, DC.

Appendix C

[Front page and table of contents]

COMMITTEE ON GENETICALLY MODIFIED PEST-PROTECTED PLANTS

PUBLIC WORKSHOP

NATIONAL RESEARCH COUNCIL BOARD ON AGRICULTURE AND NATURAL RESOURCES

May 24, 1999

AGENDA

8:30 - 9:00 am Introduction to Workshop

Perry Adkisson, Committee Chair Overview of Coordinated Regulatory Framework Stanley Abramson, Committee Member

9:00 - 10:00 Panel A: Molecular Biologists/Traditional Plant Breeders Panel

• Do transgenic pest-protected plants pose new, or different risks and benefits compared to traditionally bred plants?
• What are the differences, if any?
• What are the similarities?
• How should the regulatory scheme account for the differences or similarities?

Marlin Rice Professor, Department of Entomology Iowa State University

James Cook R. James Cook Endowed Chair in Wheat Research, Department of Plant Pathology, Crops and Soils Washington State University

Doreen Stabinsky Assistant Professor Department of Environmental Studies California State University

Richard Allison Professor, Department of Botany and Plant Pathology Michigan State University

10:00-10:15 Break

10:15 -11:15 Panel B: Commodity and Sustainable Agriculture Panel

• What are the effects of genetically modified pest-protected plants on farming practices and/or farmers?
• What are the effects of the regulation of these plants on farming practices and/or farmers?
• Do GMPP plants have a role to play in sustainable agriculture for the future?

Robert Mustell Vice President for Marketing National Corn Growers Association

Tim Debus Director for Industry Coalitions United Fresh Fruit and Vegetable Association

Kathryn DiMatteo Executive Director Organic Trade Association.

Rick Welsh Policy Analyst Wallace Institute

11:15 - 12:15 Panel C: Ecological Effects Panel

• What evidence is available concerning potential ecological risks or benefits associated with GMPP plants? (e.g. non-target species, resistance management, habitat considerations, biodiversity, reduced pesticide use)
• How should the regulatory framework address these risks and benefits?

Harold Coble Professor, Department of Crop Science North Carolina State University

Peter Kareiva Senior Scientist, Fish and Wildlife Service Department of Interior

Phil Regal Professor Department of Ecology, Evolution, and Behavior University of Minnesota

Guenther Stotzky Professor, Department of Biology New York University

12:15 - 1:15pm Lunch break

1:15 - 2:15 Panel D: Animal/Human Health Effects Panel

• What evidence is available concerning potential risks or benefits that GMPP plants pose to livestock or human health? (e.g. allergenicity, toxicity, reduced pesticide exposure)
• How should the regulatory framework address these risks and benefits?.Appendix C 251

Steven Druker Executive Director Alliance for Biointegrity

Hugh Sampson Professor, School of Medicine Immunobiology Center The Mt. Sinai School of Medicine

John Trumble Professor, Department of Entomology University of California, Riverside

Vasilios Frankos Principal Environ, Life Sciences Division

2:15 - 3:45 Panel E: Coordinated Regulatory Framework Perspectives Panel

• How effectively does the coordinated framework for the regulation of biotechnology address the scientific risks?
• What are the weaknesses?
• What are the strengths?
• What role does each agency play in the framework?
• Are these roles essential to address the risks?
• Are existing laws sufficient?
• Bob Harness Monsanto Company
• Nina Fedoroff Willaman Professor of Life Sciences, Director Life Sciences Consortium, and Director Biotechnology Institute Pennsylvania State University
• Marc Lappe Director Center for Ethics and Toxics.Genetically Modified Pest-Protected Plants: Science and Regulation 252
• Margaret Mellon Agriculture and Biotechnology Program Director Union of Concerned Scientists
• Dennis Gonsalves Liberty Hyde Bailey Professor Department of Plant Pathology Cornell University
• Resource Panel - To supplement the panel and answer questions of fact about the coordinated regulatory framework
• Janet Anderson Director Biopesticides and Pollution Prevention Division Environmental Protection Agency
• James Maryanski Strategic Manager for Biotechnology, Center for Food Safety and Applied Nutrition U.S. Food and Drug Administration
• Sally McCammon Science Advisor Animal and Plant Health Inspection Service U.S. Department of Agriculture

3:45 - 4:00 Break

4:00 - 4:45 Voluntary comments from audience at the workshop

• What comments, suggestions, or information does the audience have pertaining to the committee's review of the scientific risks/benefits of genetically modified pest protected plants and of the scientific basis for the regulatory review of these plants?

4:45 - 5:00 Summary Remarks

Perry Adkisson, Committee Chair